Clinical Trial Results:
Safety and efficacy study of TPV boosted with low dose ritonavir (TPV/r) 500 mg/200 mg BID in antiretroviral treatment experienced HIV positive patients with HCV or HBV co-infection, with a pilot evaluation of therapeutic drug monitoring (TDM).
An open-label, multicenter, multinational trial with randomisation to standard of care (SOC) or TDM TPV/r therapy
Summary
|
|
EudraCT number |
2005-005023-33 |
Trial protocol |
FR PT ES DE IT |
Global completion date |
08 Oct 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
16 May 2016
|
First version publication date |
04 Apr 2015
|
Other versions |
|
Summary report(s) |
1182.99 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.